National Center for Toxicology Research, US. Food and Drug Administration, USA.
Kaohsiung J Med Sci. 2012 Jul;28(7 Suppl):S5-9. doi: 10.1016/j.kjms.2012.05.003. Epub 2012 Jul 10.
Regulatory science plays a vital role in protecting and promoting global public health by providing the scientific basis for ensuring that food and medical products are safe, properly labeled, and effective. Regulatory science research was first developed for the determination of product safety in the early part of the 20th Century, and continues to support innovation of the processes needed for regulatory policy decisions. Historically, public health laws and regulations were enacted following public health tragedies, and often the research tools and techniques required to execute these laws lagged behind the public health needs. Throughout history, similar public health problems relating to food and pharmaceutical products have occurred in countries around the world, and have usually led to the development of equivalent solutions. For example, most countries require a demonstration of pharmaceutical safety and efficacy prior to marketing these products using approaches that are similar to those initiated in the United States. The globalization of food and medical products has created a shift in regulatory compliance such that gaps in food and medical product safety can generate international problems. Improvements in regulatory research can advance the regulatory paradigm toward a more preventative, proactive framework. These improvements will advance at a greater pace with international collaboration by providing additional resources and new perspectives for approaching and anticipating public health problems. The following is a review of how past public health disasters have shaped the current regulatory landscape, and where innovation can facilitate the shift from reactive policies to proactive policies.
监管科学在保护和促进全球公共卫生方面发挥着至关重要的作用,为确保食品和医疗产品的安全性、正确标注和有效性提供了科学依据。监管科学研究最初是为了在 20 世纪早期确定产品安全性而开发的,并且一直支持监管政策决策所需的创新过程。从历史上看,公共卫生法律法规是在公共卫生悲剧发生后颁布的,而执行这些法律所需的研究工具和技术往往落后于公共卫生需求。在历史上,与食品和药品相关的类似公共卫生问题在世界各国都曾发生过,并且通常导致了类似的解决方案的发展。例如,大多数国家要求在营销这些产品之前证明其安全性和疗效,其采用的方法类似于美国最初提出的方法。食品和医疗产品的全球化使得监管合规发生了转变,因此食品和医疗产品安全方面的差距可能会引发国际问题。监管研究的改进可以将监管模式推进到一个更具预防性、更主动的框架。通过提供更多资源和新的视角来应对和预测公共卫生问题,国际合作将加速这些改进。以下是对过去的公共卫生灾难如何塑造当前监管格局的回顾,以及创新如何促进从被动政策向主动政策的转变。